SEPSIS诊断市场Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Blood Culture Media, Assay Kits & Reagents, Software); By Technology; By Pathogen; By Testing Type; By Regions; Segment Forecast, 2020 - 2027

Report Summary

全球脓毒症诊断市场于2019年的548.2百万美元估价，预计预测期内的CAGR增长8.5％。负责市场增长的关键因素是低收入和中等收入国家的无人看管的脓毒症案例，加上了偏远农村地区的政府医院建设，脓毒症诊断的创新与新的生物标志物的出现以及引进技术先进的SEPSIS诊断自动化系统。

Know more about this report:请求样本页面

败血症是一种严重的医疗状况，受到任何感染发作的强烈免疫应答引发的。全球普遍存在对人类的巨大威胁。根据世卫组织的统计数据，2018年，全球超过3000万人遭受败血症，令人惊叹的年死亡率为5％。它还指出，每年约有300万婴儿和120万儿童患有这种情况。这种需求侧因素对于市场增长至关重要。

例如，2018年10月，基于美国的杜克大学医院介绍了“败血区”AI系统，以确定应急和重症监护病房患者脓毒症早期阶段的发病。该系统确定了健康指标，如医疗历史，实验室测试和生命体征。该系统能够每5分钟提取患者的数据以评估医疗条件。它提醒医院的护士根据患者在市场上推出的幸存败血症计划使用标准协议的情况来提出知情决策。

行业动态

增长司机
The major triggering factors for market growth for sepsis include hospital-acquired infections (HAIs), particularly in old age, infants, and people suffering from some co-morbidities. As per the estimates of the Center for Disease and Control (CDC), every year almost 1.7 million people suffer from HAIs and around 99,000 patients die due to the lack of medical care in the U.S. alone. Hence, the economic burden on the people is huge, with the majority of the revenue in the market churned from the sepsis diagnostics and treatment procedure.

目前的测试是耗时的，平均测试时间可达72小时，以破译最终结果和关键观察。因此，对早期诊断市场的护理点和快速脓毒症测试试剂盒的需求可以节省数百万的生命。符合这一点，2019年2月，研究人员在Strathclyde大学学习开发了一种具有成本效益的败血症诊断系统。它使用插入血管中的微电极并分析了两分钟和半分钟内的血阶。市场的主要球员与大学合作，使发达的系统可行，公司可以拥有一流的优势。

In line with this, there is an increased industry activity, for instance, in September 2020, Barcelona based, Loop Diagnostics, developed a point of care diagnosis platform. According to the company’s claim, the product would replace traditional methods of blood culture analysis. The basic idea was to identify bacterial infections via blood-based markers and would be able to provide test results in two hours with a 99 percent accuracy rate. The cost of the diagnosis with this system would be USD 70, as per the company claim. Early diagnosis, also opines lesser hospital expense on sepsis treatment. As per the independent survey in the market, 2018, the cost of sepsis treatment upon admission is almost USD 22,000, in comparison to USD 70,000 per patient for hospital-acquired sepsis.

SEPSIS诊断市场Report Scope

The market is primarily segmented on the basis of product, technology, pathogen, testing type, and region.

By Product	By Technology	By Pathogen	通过测试类型	By Region
仪器 血液文化媒体 Assay Kits & Reagents 软件	微生物学 Molecular Diagnostics Biomarkers Immunoassays Flow Cytometry	细菌败血症 Gram-Positive Bacteria Gram-Negative Bacteria Fungal Sepsis 其他	实验室检测 PoC Testing	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) 亚太地区（日本，中国，印度，马来西亚，印度尼西亚。韩国） 拉丁美洲(Brazil, Mexico, Argentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report:请求样本页面

产品洞察力

根据该产品，全球诊断市场分为仪器，血液培养基，测定套件和试剂，以及软件。2019年，估计血液文化媒体估计为最大的份额，并预计将在研究期间保持其优势。这是由于血液文化仍然是大多数医生最优秀的最具成本效益和最具金的标准方法。

The kits & reagents market segment is anticipated to showcase the highest growth rate over the forecast period. This is attributed to the continuously rising demand for reagents & kits for diagnostic, particularly in the developed economies. As per the study published by the American Medical Association (AMA), by February 2019, sepsis was a major death cause in the hospitals and impacted the lives of around 1.7 million individuals in the U.S. Thus, with the need for rapid diagnosis in the hospitals and clinics, the sale of reagent and kits is bound to increase in the market.

Insight by Technology

On the basis of diagnostic technology, the microbiology segment held a major market share in the global market, in 2019. The segment’s high share is due to the fact that microbiology involves the identification and detection of microbes in the blood culture media, with the help of well-trained microbiologists. The molecular diagnostic segment is projected to exhibit the highest CAGR over the study period. The technique is considered as a gold standard after blood culture in pathogen identification.

地理概述

North America market accounts for one of the largest revenue holders in the global market and is likely to maintain its dominance over the study period. The favorable reimbursement scenario for the diagnostic tests, well developed medical and clinical infrastructure, intellectual ability of the key players operating in the country.

Moreover, the country with high disposable income and spending patterns, bound to attract the vested interest of the key diagnostics companies in the market. According to the data reported by the health economist of the U.S.-based CDC National Healthcare Safety Network, the annual burden of HAIs in the U.S. alone stood between USD 28 to USD 45 billion each year.

Asia Pacific market is anticipated to exhibit a lucrative growth rate over the projected period for diagnostics. The rising cases of sepsis both in hospital and non-hospital settings with increasing medical literacy and awareness, rising insurance penetration rate, and the rise in per capita medical expense from the rural areas in the countries across the region. As per estimates of the PLOS, in 2019, India had a very high incidence rate for clinical sepsis, and it also impacted the lives of sufferers.

Competitive Insight

运营市场的一些主要参与者包括BioMérieux，轴盾诊断，Becton Dickinson，Danaher Corporation，Abbott Laboratories，Luminex，Thermo Fisher Scientific，EKF诊断，免疫抑制，Bruker，Roche Diagnostics，T​​2生物系统，响应生物医学和细胞系统。